Skip to content
healthcare.dev

Nelarabine

NDC 70710-1839, Nelarabine, injection, from Zydus Pharmaceuticals USA Inc..

Product NDC
70710-1839
Status
Listed
Labeler
Zydus Pharmaceuticals USA Inc.
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA215037
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70710-1839 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NELARABINE5 mg/mL

Pharmacologic classes

Nucleic Acid Synthesis Inhibitors [MoA]; Nucleoside Metabolic Inhibitor [EPC]

Package NDCNDC-11Package
70710-1839-1707101839011 VIAL, SINGLE-DOSE in 1 CARTON (70710-1839-1) / 50 mL in 1 VIAL, SINGLE-DOSE
70710-1839-8707101839086 VIAL, SINGLE-DOSE in 1 CARTON (70710-1839-8) / 50 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/8cb23281-93ca-40b8-b8e0-c57dd4298322
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=70710-1839

Use it

Look up 70710-1839 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70710-1839 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70710-1839. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.